CoChat

Fractionated aminolevulinic acid–photodynamic therapy provides additional evidence for the use of PDT for non‐melanoma skin cancer

De Haas, ERM, De Vijlder, HC, Sterenborg, HJCM, Neumann, HAM, Robinson, DJ · 2008 · Journal of the European Academy of Dermatology and Venereology
Cited by 73

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Background Photodynamic therapy (PDT) is an accepted treatment for superficial basal cel carcinoma (sBCC) and Bowens disease. In Rotterdam, extensive preclinical research has lead to an optimized twofold illumination scheme for aminolevulinic acid–PDT (ALA‐PDT). Objective To provide additional evidence of ALA‐PDT for sBCC, Bowens disease (BD), nodular BCC (nBCC) and actinic keratosis (AK) using a 2‐fold illumination scheme after a single application of ALA. Methods Five hundred fifty‐two lesions (430 sBCC, 20 nBCC, 32 BD, 70 AK) were treated with ALA‐PDT using a twofold illumination scheme. ALA was applied topically for 4 h. Lesions were treated with two light fractions of 20 and 80 J/cm 2 separated by a 2‐h dark interval. Results After a minimum follow‐up of 12 months, in average follow‐up of 2 years, an overall complete response of 95% was seen for all lesions. For sBCC, the complete response at 2 years was 97% (for AK 98%, for BD 84% and for nBCC 80% after 2 years). A sub‐analysis of the results of lesions larger than 2 cm showed CR at 2 years of 89% for all lesions (n = 57). Cosmetic outcome was good to excellent in 95% of the treated lesions. Conclusion ALA‐PDT using a twofold illumination scheme of 20 plus 80 J/cm 2 separated by a 2‐h dark interval leads to high complete response rates at 2 years and can be regarded as an evidence‐based treatment modality for superficial growing non‐melanoma skin cancer and the (pre)malignant AK. The Rotterdam fractionated approach should be included in future guidelines.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1468-3083.2007.02445.x

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 73

Metadata

Authors
De Haas, E., De Vijlder, H., Sterenborg, H., Neumann, H., & Robinson, D.
Venue
Journal of the European Academy of Dermatology and Venereology
Publisher
Wiley
Published
2007-11-21
Volume
22
Issue
4
Pages
426-430
ISSN
  • 0926-9959 (ISSN-L)
  • 1468-3083
OpenAlex
W2056221301
Cited by
73
References
3
FWCI
2.72
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Fractionated aminolevulinic acid–photodynamic therapy provides additional evidence for the use of PDT for non‐melanoma skin cancer. https://app.cochat.ai/papers/10.1111/j.1468-3083.2007.02445.x
The paper
De Haas, E., De Vijlder, H., Sterenborg, H., Neumann, H., & Robinson, D. (2008). Fractionated aminolevulinic acid–photodynamic therapy provides additional evidence for the use of PDT for non‐melanoma skin cancer. Journal of the European Academy of Dermatology and Venereology. https://doi.org/10.1111/j.1468-3083.2007.02445.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.